Ajax loader

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: Pharmacology

UKRAINE-CRISIS/BORDER-ROMANIA
RTS6BMG4 
March 15, 2022 
Priya Seemish, 20, rests on her mattress at Dumbraveni sports arena which has been converted to a temporary... 
Suceava, Romania 
People fleeing Russia's ongoing invasion of Ukraine arrive at Dumbraveni sports arena in Suceava 
Priya Seemish, 20, rests on her mattress at Dumbraveni sports arena which has been converted to a temporary shelter, while studying on her laptop for her Masters in Pharmacology, after she fled with her family from Kyiv in Ukraine through the Siret border crossing in Romania, following Russia's ongoing invasion of Ukraine, in Suceava, Romania March 15, 2022. REUTERS/Clodagh Kilcoyne 
HEALTH-CORONAVIRUS/PHARMAMAR
RTX8PX0O 
January 26, 2021 
Pablo Aviles, head of Nonclinical Toxicology and Pharmacology at PharmaMar, poses for a portrait at a... 
COLMENAR VIEJO, Spain 
Pablo Aviles, head of Nonclinical Toxicology and Pharmacology at PharmaMar, poses for a portrait at a... 
Pablo Aviles, head of Nonclinical Toxicology and Pharmacology at PharmaMar, poses for a portrait at a PharmaMar lab, amid the coronavirus disease (COVID-19) outbreak, in Colmenar Viejo, Spain January 26, 2021. REUTERS/Susana Vera 
GLOBAL-PHARMACEUTICAL/
RTS1UINL 
June 30, 2018 
Used blister packets that contained medicines, tablets and pills are seen, in this picture illustration... 
London, United Kingdom 
Used blister packets that contained medicines, tablets and pills are seen, in this picture illustration... 
Used blister packets that contained medicines, tablets and pills are seen, in this picture illustration taken June 30, 2018. REUTERS/Russell Boyce/Illustration 
GLOBAL-PHARMACEUTICAL/
RTS1UINK 
June 30, 2018 
Used blister packets that contained medicines, tablets and pills are seen, in this picture illustration... 
London, United Kingdom 
Used blister packets that contained medicines, tablets and pills are seen, in this picture illustration... 
Used blister packets that contained medicines, tablets and pills are seen, in this picture illustration taken June 30, 2018. REUTERS/Russell Boyce/Illustration 
GLOBAL-PHARMACEUTICAL/
RTS1UINJ 
June 30, 2018 
Used blister packets that contained medicines, tablets and pills are seen, in this picture illustration... 
London, United Kingdom 
Used blister packets that contained medicines, tablets and pills are seen, in this picture illustration... 
Used blister packets that contained medicines, tablets and pills are seen, in this picture illustration taken June 30, 2018. REUTERS/Russell Boyce/Illustration 
UPSA-PHARMACEUTICALS/
RTX5F0NJ 
March 29, 2018 
Paracetamol tablets are pictured on the production line for UPSA brand of Bristol-Myers Squibb Group... 
LE PASSAGE, France 
Paracetamol tablets are pictured on the production line for UPSA brand of Bristol-Myers Squibb Group... 
Paracetamol tablets are pictured on the production line for UPSA brand of Bristol-Myers Squibb Group at the company's factory in Le Passage, near Agen, France March 29, 2018. REUTERS/Regis Duvignau 
FRANCE-SCIENCE/
RTR4E0R9 
November 13, 2014 
Researcher Fabien Guillemot checks human cells after a bio- 3D printing with laser in the laboratory... 
Pessac, France 
Researcher Fabien Guillemot checks human cells after a bio- 3D printing with laser in the laboratory... 
Researcher Fabien Guillemot checks human cells after a bio- 3D printing with laser in the laboratory Biotis at INSERM (the National Institute for Health and Medical Research) in Pessac near Bordeaux October 29, 2014. Producing human tissue will become possible thanks to a team of Bordeaux researchers developing a new technique for bio- 3D printing with laser precision. Human tissue 3D printing will have future applications in cosmetics, pharmacology and surgery soon, especially in the field of skin transplants. Picture taken October 29, 2014. REUTERS/Regis Duvignau (FRANCE - Tags: SCIENCE TECHNOLOGY) 
FRANCE-SCIENCE/
RTR4E0R3 
November 13, 2014 
Researchers work in the laboratory Biotis at INSERM (the National Institute for Health and Medical Research)... 
Pessac, France 
Researchers work in the laboratory Biotis at INSERM Institute in Pessac near Bordeaux 
Researchers work in the laboratory Biotis at INSERM (the National Institute for Health and Medical Research) in Pessac near Bordeaux October 29, 2014. Producing human tissue will become possible thanks to a team of Bordeaux researchers developing a new technique for bio- 3D printing with laser precision. Human tissue 3D printing will have future applications in cosmetics, pharmacology and surgery soon, especially in the field of skin transplants. Picture taken October 29, 2014. REUTERS/Regis Duvignau (FRANCE - Tags: SCIENCE TECHNOLOGY) 
FRANCE-SCIENCE/
RTR4E0QP 
November 13, 2014 
Researcher Fabien Guillemot poses in the laboratory Biotis at INSERM (the National Institute for Health... 
Pessac, France 
Researcher Fabien Guillemot poses in the laboratory Biotis at INSERM Institute in Pessac near Bordeaux... 
Researcher Fabien Guillemot poses in the laboratory Biotis at INSERM (the National Institute for Health and Medical Research) in Pessac near Bordeaux October 29, 2014. Producing human tissue will become possible thanks to a team of Bordeaux researchers developing a new technique for bio- 3D printing with laser precision. Human tissue 3D printing will have future applications in cosmetics, pharmacology and surgery soon, especially in the field of skin transplants. Picture taken October 29, 2014. REUTERS/Regis Duvignau (FRANCE - Tags: SCIENCE TECHNOLOGY HEADSHOT) 
FRANCE-SCIENCE/
RTR4E0QG 
November 13, 2014 
A researcher prepares liquid droplets containing human cells before a bio- 3D printing with laser in... 
Pessac, France 
A researcher prepares liquid droplets containing human cells before a bio- 3D printing with laser in... 
A researcher prepares liquid droplets containing human cells before a bio- 3D printing with laser in the laboratory Biotis at INSERM (the National Institute for Health and Medical Research) in Pessac near Bordeaux October 29, 2014. Producing human tissue will become possible thanks to a team of Bordeaux researchers developing a new technique for bio- 3D printing with laser precision. Human tissue 3D printing will have future applications in cosmetics, pharmacology and surgery soon, especially in the field of skin transplants. Picture taken October 29, 2014. REUTERS/Regis Duvignau (FRANCE - Tags: SCIENCE TECHNOLOGY) 
FRANCE-SCIENCE/
RTR4E0QB 
November 13, 2014 
A researcher uses a microscope after a laser bio- 3D printing of human cells in the laboratory Biotis... 
Pessac, France 
A researcher uses a microscope after a laser bio- 3D printing of human cells in the laboratory Biotis... 
A researcher uses a microscope after a laser bio- 3D printing of human cells in the laboratory Biotis at INSERM (the National Institute for Health and Medical Research) in Pessac near Bordeaux October 29, 2014. Producing human tissue will become possible thanks to a team of Bordeaux researchers developing a new technique for bio- 3D printing with laser precision. Human tissue 3D printing will have future applications in cosmetics, pharmacology and surgery soon, especially in the field of skin transplants. Picture taken October 29, 2014. REUTERS/Regis Duvignau (FRANCE - Tags: SCIENCE TECHNOLOGY) 
FRANCE-SCIENCE/
RTR4E0PS 
November 13, 2014 
A researcher prepares liquid droplets containing human cells before a bio- 3D printing with laser in... 
Pessac, France 
A researcher prepares liquid droplets containing human cells before a bio- 3D printing with laser in... 
A researcher prepares liquid droplets containing human cells before a bio- 3D printing with laser in the laboratory Biotis at INSERM (the National Institute for Health and Medical Research) in Pessac near Bordeaux October 29, 2014. Producing human tissue will become possible thanks to a team of Bordeaux researchers developing a new technique for bio- 3D printing with laser precision. Human tissue 3D printing will have future applications in cosmetics, pharmacology and surgery soon, especially in the field of skin transplants. Picture taken October 29, 2014. REUTERS/Regis Duvignau (FRANCE - Tags: SCIENCE TECHNOLOGY) 
FRANCE-SCIENCE/
RTR4E0PP 
November 13, 2014 
The liquid used for the laser bio- 3D printing of human cells is pictured in the laboratory Biotis at... 
Pessac, France 
The liquid used for the laser bio- 3D printing of human cells is pictured in the laboratory Biotis at... 
The liquid used for the laser bio- 3D printing of human cells is pictured in the laboratory Biotis at INSERM (the National Institute for Health and Medical Research) in Pessac near Bordeaux October 29, 2014. Producing human tissue will become possible thanks to a team of Bordeaux researchers developing a new technique for bio- 3D printing with laser precision. Human tissue 3D printing will have future applications in cosmetics, pharmacology and surgery soon, especially in the field of skin transplants. Picture taken October 29, 2014. REUTERS/Regis Duvignau (FRANCE - Tags: SCIENCE TECHNOLOGY) 
FRANCE-SCIENCE/
RTR4E0PH 
November 13, 2014 
A researcher looks at a screen with a picture of human cells after a laser bio- 3D printing in the laboratory... 
Pessac, France 
A researcher looks at a screen with a picture of human cells after a laser bio- 3D printing in the laboratory... 
A researcher looks at a screen with a picture of human cells after a laser bio- 3D printing in the laboratory Biotis at INSERM (the National Institute for Health and Medical Research) in Pessac near Bordeaux October 29, 2014. Producing human tissue will become possible thanks to a team of Bordeaux researchers developing a new technique for bio- 3D printing with laser precision. Human tissue 3D printing will have future applications in cosmetics, pharmacology and surgery soon, especially in the field of skin transplants. Picture taken October 29, 2014. REUTERS/Regis Duvignau (FRANCE - Tags: SCIENCE TECHNOLOGY) 
FRANCE-SCIENCE/
RTR4E0P5 
November 13, 2014 
Researcher Fabien Guillemot checks the human cells during a bio- 3D printing in the laboratory Biotis... 
Pessac, France 
Researcher Fabien Guillemot checks the human cells during a bio- 3D printing in the laboratory Biotis... 
Researcher Fabien Guillemot checks the human cells during a bio- 3D printing in the laboratory Biotis at INSERM (the National Institute for Health and Medical Research) in Pessac near Bordeaux October 29, 2014. Producing human tissue will become possible thanks to a team of Bordeaux researchers developing a new technique for bio- 3D printing with laser precision. Human tissue 3D printing will have future applications in cosmetics, pharmacology and surgery soon, especially in the field of skin transplants. Picture taken October 29, 2014. REUTERS/Regis Duvignau (FRANCE - Tags: SCIENCE TECHNOLOGY) 
FRANCE-SCIENCE/
RTR4E0OW 
November 13, 2014 
A researcher checks a laser bio- 3D printing in the laboratory Biotis at INSERM (the National Institute... 
Pessac, France 
A researcher checks a laser bio- 3D printing in the laboratory Biotis at INSERM Institute in Pessac near... 
A researcher checks a laser bio- 3D printing in the laboratory Biotis at INSERM (the National Institute for Health and Medical Research) in Pessac near Bordeaux October 29, 2014. Producing human tissue will become possible thanks to a team of Bordeaux researchers developing a new technique for bio- 3D printing with laser precision. Human tissue 3D printing will have future applications in cosmetics, pharmacology and surgery soon, especially in the field of skin transplants. Picture taken October 29, 2014. REUTERS/Regis Duvignau (FRANCE - Tags: SCIENCE TECHNOLOGY) 
FRANCE-SCIENCE/
RTR4E0OR 
November 13, 2014 
Researcher Fabien Guillemot checks the human cells after a bio- 3D printing with laser in the laboratory... 
Pessac, France 
Researcher Fabien Guillemot checks the human cells after a bio- 3D printing with laser in the laboratory... 
Researcher Fabien Guillemot checks the human cells after a bio- 3D printing with laser in the laboratory Biotis at INSERM (the National Institute for Health and Medical Research) in Pessac near Bordeaux October 29, 2014. Producing human tissue will become possible thanks to a team of Bordeaux researchers developing a new technique for bio- 3D printing with laser precision. Human tissue 3D printing will have future applications in cosmetics, pharmacology and surgery soon, especially in the field of skin transplants. Picture taken October 29, 2014. REUTERS/Regis Duvignau (FRANCE - Tags: SCIENCE TECHNOLOGY) 
FRANCE-SCIENCE/
RTR4E0O7 
November 13, 2014 
A researcher prepares liquid droplets containing human cells before a bio- 3D printing with laser in... 
Pessac, France 
A researcher prepares liquid droplets containing human cells before a bio- 3D printing with laser in... 
A researcher prepares liquid droplets containing human cells before a bio- 3D printing with laser in the laboratory Biotis at INSERM (the National Institute for Health and Medical Research) in Pessac near Bordeaux October 29, 2014. Producing human tissue will become possible thanks to a team of Bordeaux researchers developing a new technique for bio- 3D printing with laser precision. Human tissue 3D printing will have future applications in cosmetics, pharmacology and surgery soon, especially in the field of skin transplants. Picture taken October 29, 2014. REUTERS/Regis Duvignau (FRANCE - Tags: SCIENCE TECHNOLOGY) 
BRITAIN/
RTR308R3 
April 02, 2012 
Visitors view "Trinity -Pharmacology, Physiology, Pathology" by British artist Damien Hirst at the Tate... 
London, United Kingdom 
Visitors view "Trinity -Pharmacology, Physiology, Pathology" by British artist Damien Hirst at the Tate... 
Visitors view "Trinity -Pharmacology, Physiology, Pathology" by British artist Damien Hirst at the Tate Modern gallery in London April 2, 2012. Hirst's retrospective show runs from April 4 to September 9. REUTERS/Toby Melville (BRITAIN - Tags: ENTERTAINMENT SOCIETY) 
INDIA-DRUGS/ANALYSIS
RTR2ZA0X 
March 13, 2012 
A pharmacologist checks the reaction on a nude mouse after applying the SNB cytotoxic drugs for anti-tumour... 
Hyderabad, India 
A pharmacologist checks the reaction on a nude mouse after applying the SNB cytotoxic drugs for anti-tumour... 
A pharmacologist checks the reaction on a nude mouse after applying the SNB cytotoxic drugs for anti-tumour cancer inside the bio safety cabinet at Natco Research Centre in the southern Indian city of Hyderabad March 13, 2012. India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say. On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug cheaply in India. REUTERS/Krishnendu Halder (INDIA - Tags: HEALTH ANIMALS) 
RUSSIA/
RTR24PE7 
June 16, 2009 
A Siberian maral, a subspecies of deer, attacks people as it is led to have its antlers cut at a farm... 
SALBA, Russia 
A Siberian maral, a subspecies of deer, attacks people as it is led to have its antlers cut at a farm... 
A Siberian maral, a subspecies of deer, attacks people as it is led to have its antlers cut at a farm near the village of Salba, some 610 km (379 miles) southeast of the Siberian city of Krasnoyarsk, June 15, 2009. Over 600 marals at this private farm undergo an annual cutting of their antlers, to be sold to pharmacological companies in Russia, China, Korea and South East Asia. Picture taken 15 June, 2009. REUTERS/Ilya Naymushin (RUSSIA SOCIETY ANIMALS) 
RUSSIA/
RTR24PE2 
June 16, 2009 
A Siberian maral, a subspecies of deer, is held in a special device as it has its antlers cut at a farm... 
SALBA, Russia 
A Siberian maral, a subspecies of deer, is held in a special device as it has its antlers cut at a farm... 
A Siberian maral, a subspecies of deer, is held in a special device as it has its antlers cut at a farm near the village of Salba, some 610 km (379 miles) southeast of the Siberian city of Krasnoyarsk, June 15, 2009. Over 600 marals at this private farm undergo an annual cutting of their antlers, to be sold to pharmacological companies in Russia, China, Korea and South East Asia. Picture taken 15 June, 2009. REUTERS/Ilya Naymushin (RUSSIA SOCIETY ANIMALS) 
RUSSIA/
RTR24PDZ 
June 16, 2009 
A worker weighs the antlers of Siberian marals, a subspecies of deer, after the annual cutting of their... 
SALBA, Russia 
A worker weighs the antlers of Siberian marals, a subspecies of deer, after the annual cutting of their... 
A worker weighs the antlers of Siberian marals, a subspecies of deer, after the annual cutting of their antlers at a farm near the village of Salba, some 610 km (379 miles) southeast of the Siberian city of Krasnoyarsk, June 15, 2009. Over 600 marals at this private farm undergo an annual cutting of their antlers, to be sold to pharmacological companies in Russia, China, Korea and South East Asia. Picture taken 15 June, 2009. REUTERS/Ilya Naymushin (RUSSIA SOCIETY ANIMALS) 
RUSSIA/
RTR24PDV 
June 16, 2009 
A man looks at the antlers of Siberian marals, a subspecies of deer, after the annual cutting of their... 
SALBA, Russia 
A man looks at the antlers of Siberian marals, a subspecies of deer, after the annual cutting of their... 
A man looks at the antlers of Siberian marals, a subspecies of deer, after the annual cutting of their antlers at a farm near the village of Salba, some 610 km (379 miles) southeast of the Siberian city of Krasnoyarsk, June 15, 2009. Over 600 marals at this private farm undergo an annual cutting of their antlers, to be sold to pharmacological companies in Russia, China, Korea and South East Asia. Picture taken 15 June, 2009. REUTERS/Ilya Naymushin (RUSSIA SOCIETY ANIMALS) 
RUSSIA/
RTR24PDT 
June 16, 2009 
Workers measure and register the antlers of Siberian marals, a subspecies of deer, after the annual cutting... 
SALBA, Russia 
Workers measure and register the antlers of Siberian marals, a subspecies of deer, after the annual cutting... 
Workers measure and register the antlers of Siberian marals, a subspecies of deer, after the annual cutting of their antlers at a farm near the village of Salba, some 610 km (379 miles) southeast of the Siberian city of Krasnoyarsk, June 15, 2009. Over 600 marals at this private farm undergo an annual cutting of their antlers, to be sold to pharmacological companies in Russia, China, Korea and South East Asia. Picture taken 15 June, 2009. REUTERS/Ilya Naymushin (RUSSIA SOCIETY ANIMALS) 
RUSSIA/
RTR24PDS 
June 16, 2009 
A man measures and registers the antlers of Siberian marals, a subspecies of deer, after the annual cutting... 
SALBA, Russia 
A man measures and registers the antlers of Siberian marals, a subspecies of deer, after the annual cutting... 
A man measures and registers the antlers of Siberian marals, a subspecies of deer, after the annual cutting of their antlers at a farm near the village of Salba, some 610 km (379 miles) southeast of the Siberian city of Krasnoyarsk, June 15, 2009. Over 600 marals at this private farm undergo an annual cutting of their antlers, to be sold to pharmacological companies in Russia, China, Korea and South East Asia. Picture taken 15 June, 2009. REUTERS/Ilya Naymushin (RUSSIA SOCIETY ANIMALS) 
RUSSIA/
RTR24PDJ 
June 16, 2009 
Siberian marals, a subspecies of deer, walk through the taiga at a farm, near the village of Salba, some... 
SALBA, Russia 
Siberian marals, a subspecies of deer, walk through the taiga at a farm, near the village of Salba 
Siberian marals, a subspecies of deer, walk through the taiga at a farm, near the village of Salba, some 610 km (379 miles) southeast of the Siberian city of Krasnoyarsk, June 15, 2009. Over 600 marals at this private farm undergo an annual cutting of their antlers, to be sold to pharmacological companies in Russia, China, Korea and South East Asia. Picture taken 15 June, 2009. REUTERS/Ilya Naymushin (RUSSIA SOCIETY ANIMALS) 
RUSSIA/
RTR24PDI 
June 16, 2009 
A Siberian maral, a subspecies of deer, is held in a special device as it has its antlers cut at a farm... 
SALBA, Russia 
A Siberian maral, a subspecies of deer, is held in a special device as it has its antlers cut at a farm... 
A Siberian maral, a subspecies of deer, is held in a special device as it has its antlers cut at a farm near the village of Salba, some 610 km (379 miles) southeast of the Siberian city of Krasnoyarsk, June 15, 2009. Over 600 marals at this private farm undergo an annual cutting of their antlers, to be sold to pharmacological companies in Russia, China, Korea and South East Asia. Picture taken 15 June, 2009. REUTERS/Ilya Naymushin (RUSSIA SOCIETY ANIMALS) 
RUSSIA/
RTR24PDH 
June 16, 2009 
A Siberian maral, a subspecies of deer, is held in a special device as it has its antlers cut at a farm... 
SALBA, Russia 
A Siberian maral, a subspecies of deer, is held in a special device as it has its antlers cut at a farm... 
A Siberian maral, a subspecies of deer, is held in a special device as it has its antlers cut at a farm near the village of Salba, some 610 km (379 miles) southeast of the Siberian city of Krasnoyarsk, June 15, 2009. Over 600 marals at this private farm undergo an annual cutting of their antlers, to be sold to pharmacological companies in Russia, China, Korea and South East Asia. Picture taken 15 June, 2009. REUTERS/Ilya Naymushin (RUSSIA SOCIETY ANIMALS) 
RUSSIA/
RTR24PDE 
June 16, 2009 
A Siberian maral, a subspecies of deer, is held in a special device as it has its antlers cut at a farm... 
SALBA, Russia 
A Siberian maral, a subspecies of deer, is held in a special device as it has its antlers cut at a farm... 
A Siberian maral, a subspecies of deer, is held in a special device as it has its antlers cut at a farm near the village of Salba, some 610 km (379 miles) southeast of the Siberian city of Krasnoyarsk, June 15, 2009. Over 600 marals at this private farm undergo an annual cutting of their antlers, to be sold to pharmacological companies in Russia, China, Korea and South East Asia. Picture taken 15 June, 2009. REUTERS/Ilya Naymushin (RUSSIA SOCIETY ANIMALS) 
RUSSIA/
RTR24PDC 
June 16, 2009 
A Siberian maral, a subspecies of deer, is led to have its antlers cut at a farm, near the village of... 
SALBA, Russia 
A Siberian maral, a subspecies of deer, is led to have its antlers cut at a farm, near the village of... 
A Siberian maral, a subspecies of deer, is led to have its antlers cut at a farm, near the village of Salba, some 610 km (379 miles) southeast of the Siberian city of Krasnoyarsk, June 15, 2009. Over 600 marals at this private farm undergo an annual cutting of their antlers, to be sold to pharmacological companies in Russia, China, Korea and South East Asia. Picture taken 15 June, 2009. REUTERS/Ilya Naymushin (RUSSIA SOCIETY ANIMALS) 
RUSSIA/
RTR24PCQ 
June 16, 2009 
A Siberian maral, a subspecies of deer, jumps at a farm before the annual cutting of antlers, near the... 
SALBA, Russia 
A Siberian maral, a subspecies of deer, jumps at a farm before the annual cutting of antlers, near the... 
A Siberian maral, a subspecies of deer, jumps at a farm before the annual cutting of antlers, near the village of Salba, some 610 km (379 miles) southeast of the Siberian city of Krasnoyarsk, June 15, 2009. Over 600 marals at this private farm undergo an annual cutting of their antlers, to be sold to pharmacological companies in Russia, China, Korea and South East Asia. Picture taken 15 June, 2009. REUTERS/Ilya Naymushin (RUSSIA SOCIETY ANIMALS) 
RUSSIA/
RTR24PCN 
June 16, 2009 
A Siberian maral, a subspecies of deer, jumps at a farm after the annual cutting of antlers, near the... 
SALBA, Russia 
A Siberian maral, a subspecies of deer, jumps at a farm after the annual cutting of antlers, near the... 
A Siberian maral, a subspecies of deer, jumps at a farm after the annual cutting of antlers, near the village of Salba, some 610 km (379 miles) southeast of the Siberian city of Krasnoyarsk, June 15, 2009. Over 600 marals at this private farm undergo an annual cutting of their antlers, to be sold to pharmacological companies in Russia, China, Korea and South East Asia. Picture taken 15 June, 2009. REUTERS/Ilya Naymushin (RUSSIA SOCIETY ANIMALS) 
RUSSIA/
RTR24PCK 
June 16, 2009 
Siberian marals, a subspecies of deer, gather at a farm after the annual cutting of antlers, near the... 
SALBA, Russia 
Siberian marals, a subspecies of deer, gather at a farm after the annual cutting of antlers, near the... 
Siberian marals, a subspecies of deer, gather at a farm after the annual cutting of antlers, near the village of Salba, some 610 km (379 miles) southeast of the Siberian city of Krasnoyarsk, June 15, 2009. Over 600 marals at this private farm undergo an annual cutting of their antlers, to be sold to pharmacological companies in Russia, China, Korea and South East Asia. Picture taken 15 June, 2009. REUTERS/Ilya Naymushin (RUSSIA SOCIETY ANIMALS) 
RUSSIA/
RTR24PCD 
June 16, 2009 
A Siberian maral, a subspecies of deer, has its antlers cut at a farm, near the village of Salba, some... 
SALBA, Russia 
A Siberian maral, a subspecies of deer, has its antlers cut at a farm, near the village of Salba 
A Siberian maral, a subspecies of deer, has its antlers cut at a farm, near the village of Salba, some 610 km (379 miles) southeast of the Siberian city of Krasnoyarsk, June 15, 2009. Over 600 marals at this private farm undergo an annual cutting of their antlers, to be sold to pharmacological companies in Russia, China, Korea and South East Asia. Picture taken 15 June, 2009. REUTERS/Ilya Naymushin (RUSSIA SOCIETY ANIMALS) 
RUSSIA/
RTR24PC9 
June 16, 2009 
A Siberian maral, a subspecies of deer, has its antlers cut at a farm, near the village of Salba, some... 
SALBA, Russia 
A Siberian maral, a subspecies of deer, has its antlers cut at a farm, near the village of Salba 
A Siberian maral, a subspecies of deer, has its antlers cut at a farm, near the village of Salba, some 610 km (379 miles) southeast of the Siberian city of Krasnoyarsk, June 15, 2009. Over 600 marals at this private farm undergo an annual cutting of their antlers, to be sold to pharmacological companies in Russia, China, Korea and South East Asia. Picture taken 15 June, 2009. REUTERS/Ilya Naymushin (RUSSIA SOCIETY ANIMALS) 
RUSSIA/
RTR24PBZ 
June 16, 2009 
Siberian marals, a subspecies of deer, run at a farm before the annual cutting of antlers, near the village... 
SALBA, Russia 
Siberian marals, a subspecies of deer, run at a farm before the annual cutting of antlers, near the village... 
Siberian marals, a subspecies of deer, run at a farm before the annual cutting of antlers, near the village of Salba, some 610 km (379 miles) southeast of the Siberian city of Krasnoyarsk, June 15, 2009. Over 600 marals at this private farm undergo an annual cutting of their antlers, to be sold to pharmacological companies in Russia, China, Korea and South East Asia. Picture taken 15 June, 2009. REUTERS/Ilya Naymushin (RUSSIA SOCIETY ANIMALS) 
RUSSIA/
RTR24PBU 
June 16, 2009 
Siberian marals, a subspecies of deer, gather at a farm after the annual cutting of antlers, near the... 
SALBA, Russia 
Siberian marals, a subspecies of deer, gather at a farm after the annual cutting of antlers, near the... 
Siberian marals, a subspecies of deer, gather at a farm after the annual cutting of antlers, near the village of Salba, some 610 km (379 miles) southeast of the Siberian city of Krasnoyarsk, June 15, 2009. Over 600 marals at this private farm undergo an annual cutting of their antlers, to be sold to pharmacological companies in Russia, China, Korea and South East Asia. Picture taken 15 June, 2009. REUTERS/Ilya Naymushin (RUSSIA SOCIETY ANIMALS) 
RUSSIA/
RTR24PBD 
June 16, 2009 
Siberian marals, a subspecies of deer, gather at a farm after the annual cutting of antlers, near the... 
SALBA, Russia 
Siberian marals, a subspecies of deer, gather at a farm after the annual cutting of antlers, near the... 
Siberian marals, a subspecies of deer, gather at a farm after the annual cutting of antlers, near the village of Salba, some 610 km (379 miles) southeast of the Siberian city of Krasnoyarsk, June 15, 2009. Over 600 marals at this private farm undergo an annual cutting of their antlers, to be sold to pharmacological companies in Russia, China, Korea and South East Asia. Picture taken 15 June, 2009. REUTERS/Ilya Naymushin (RUSSIA SOCIETY ANIMALS) 
RUSSIA/
RTR24PBA 
June 16, 2009 
A man herds Siberian marals, a subspecies of deer, at a farm before the annual cutting of antlers, near... 
SALBA, Russia 
A man herds Siberian marals, a subspecies of deer, at a farm before the annual cutting of antlers, near... 
A man herds Siberian marals, a subspecies of deer, at a farm before the annual cutting of antlers, near the village of Salba, some 610 km (379 miles) southeast of the Siberian city of Krasnoyarsk, June 15, 2009. Over 600 marals at this private farm undergo an annual cutting of their antlers, to be sold to pharmacological companies in Russia, China, Korea and South East Asia. Picture taken 15 June, 2009. REUTERS/Ilya Naymushin (RUSSIA SOCIETY ANIMALS) 
RUSSIA/
RTR24PB6 
June 16, 2009 
A man directs Siberian marals, a subspecies of deer, at a farm before the annual cutting of antlers,... 
SALBA, Russia 
A man directs Siberian marals, a subspecies of deer, at a farm before the annual cutting of antlers,... 
A man directs Siberian marals, a subspecies of deer, at a farm before the annual cutting of antlers, near the village of Salba, some 610 km (379 miles) southeast of the Siberian city of Krasnoyarsk, June 15, 2009. Over 600 marals at this private farm undergo an annual cutting of their antlers, to be sold to pharmacological companies in Russia, China, Korea and South East Asia. Picture taken 15 June, 2009. REUTERS/Ilya Naymushin (RUSSIA SOCIETY ANIMALS) 
RUSSIA/
RTR24PAR 
June 16, 2009 
Siberian marals, a subspecies of deer, gather at a farm before the annual cutting of antlers, near the... 
SALBA, Russia 
Siberian marals, a subspecies of deer, gather at a farm before the annual cutting of antlers, near the... 
Siberian marals, a subspecies of deer, gather at a farm before the annual cutting of antlers, near the village of Salba, some 610 km (379 miles) southeast of the Siberian city of Krasnoyarsk, June 15, 2009. Over 600 marals at this private farm undergo an annual cutting of their antlers, to be sold to pharmacological companies in Russia, China, Korea and South East Asia. Picture taken 15 June, 2009. REUTERS/Ilya Naymushin (RUSSIA) 
FRANCE/
RTR1WJNZ 
February 01, 2008 
France's Minister for Health, Youth and Sport Roselyne Bachelot-Narquin looks through a microscope during... 
VALBONNE, France 
France's Minister for Health, Youth and Sport Bachelot-Narquin visits the Institute of Molecular and... 
France's Minister for Health, Youth and Sport Roselyne Bachelot-Narquin looks through a microscope during a visit to the Institute of Molecular and Cellular Pharmacology, in support of the battle against Alzheimer's Disease, in Sophia Antipolis Valbonne February 1, 2008. REUTERS/Gilbert Tourte (FRANCE) 
FRANCE/
RTR1WJNW 
February 01, 2008 
France's President Nicolas Sarkozy looks through a microscope as he visits the Institute of Molecular... 
VALBONNE, France 
France's President Sarkozy looks through a microscope as he visits the Institute of Molecular and Cellular... 
France's President Nicolas Sarkozy looks through a microscope as he visits the Institute of Molecular and Cellular Pharmacology, in support of the battle against Alzheimer's Disease, in Sophia Antipolis Valbonne February 1, 2008. REUTERS/Gilbert Tourte (FRANCE) 
FRANCE/
RTR1WJNS 
February 01, 2008 
France's President Nicolas Sarkozy (R) visits the Institute of Molecular and Cellular Pharmacology, in... 
VALBONNE, France 
France's President Nicolas Sarkozy visits the Institute of Molecular and Cellular Pharmacology in Sophia... 
France's President Nicolas Sarkozy (R) visits the Institute of Molecular and Cellular Pharmacology, in support of the battle against Alzheimer's Disease, in Sophia Antipolis Valbonne February 1, 2008. Director of CNRS Frederic Checher (L) and Minister of the Interior, Overseas France and Local Authorities Christian Estrosi are seen with Sarkozy. REUTERS/Gilbert Tourte (FRANCE) 
FRANCE/
RTR1WJNK 
February 01, 2008 
France's President Nicolas Sarkozy (R) visits the Institute of Molecular and Cellular Pharmacology, in... 
VALBONNE, France 
France's President Nicolas Sarkozy (R) visits the Institute of Molecular and Cellular Pharmacology in... 
France's President Nicolas Sarkozy (R) visits the Institute of Molecular and Cellular Pharmacology, in support of the battle against Alzheimer's Disease, in Sophia Antipolis Valbonne February 1, 2008. Director of CNRS Frederic Checher (L) and Minister of the Interior, Overseas France and Local Authorities Christian Estrosi are also seen with Sarkozy. REUTERS/Gilbert Tourte (FRANCE) 
FRANCE/
RTR1WJND 
February 01, 2008 
France's President Nicolas Sarkozy (C rear) visits the Institute of Molecular and Cellular Pharmacology,... 
SOPHIA ANTIPOLIS VALBONNE, France 
France's President Nicolas Sarkozy visits the Institute of Molecular and Cellular Pharmacology in Sophia... 
France's President Nicolas Sarkozy (C rear) visits the Institute of Molecular and Cellular Pharmacology, in support of the battle against Alzheimer's Disease, in Sophia Antipolis Valbonne February 1, 2008. Director of CNRS Frederic Checher (L) and Minister of the Interior, Overseas France and Local Authorities Christian Estrosi are also seen with Sarkozy. REUTERS/Gilbert Tourte (FRANCE) 
Health
Health 
Growing Daffodils for Pharmaceuticals and Cosmetics - 24 Apr 2007 
6 PICTURES 
HEALTH BRITAIN HERCEPTIN
RTR1E8GD 
June 09, 2006 
A pharmacologist injects a phial of concentrated Herceptin in London June 9, 2006. Herceptin, the drug... 
London, United Kingdom 
Pharmacologist injects phial of concentrated Herceptin in London 
A pharmacologist injects a phial of concentrated Herceptin in London June 9, 2006. Herceptin, the drug at the centre of protests over healthcare rationing, should be used in early breast cancer and be paid for by the state health service, Britain's cost-effectiveness watchdog said on Friday. REUTERS/Luke MacGregor (BRITAIN) 
HEALTH BRITAIN HERCEPTIN
RTR1E8G6 
June 09, 2006 
A phial and pack of herceptin are seen in London June 9, 2006. Herceptin, the drug at the centre of protests... 
London, United Kingdom 
Phial and pack of Herceptin are seen in London 
A phial and pack of herceptin are seen in London June 9, 2006. Herceptin, the drug at the centre of protests over healthcare rationing, should be used in early breast cancer and be paid for by the state health service, Britain's cost-effectiveness watchdog said on Friday. REUTERS/Luke MacGregor (BRITAIN) 
HEALTH BRITAIN HERCEPTIN
RTR1E8FF 
June 09, 2006 
A pharmacologist injects a phial of concentrated herceptin with water to dilute for use, in London June... 
London, United Kingdom 
Pharmacologist injects phial of concentrated herceptin with water to dilute for use in London 
A pharmacologist injects a phial of concentrated herceptin with water to dilute for use, in London June 9, 2006. Herceptin, the drug at the centre of protests over healthcare rationing, should be used in early breast cancer and be paid for by the NHS, the cost-effectiveness watchdog said on Friday. REUTERS/Luke MacGregor (BRITAIN) 
HEALTH BRITAIN HERCEPTIN
RTR1E8FB 
June 09, 2006 
A pharmacologist holds a phial of concentrated Herceptin in London June 9, 2006. Herceptin, the drug... 
London, United Kingdom 
Pharmacologist holds phial of concentrated herceptin in London 
A pharmacologist holds a phial of concentrated Herceptin in London June 9, 2006. Herceptin, the drug at the centre of protests over healthcare rationing, should be used in early breast cancer and be paid for by the NHS, the cost-effectiveness watchdog said on Friday. REUTERS/Luke MacGregor (BRITAIN) 
NISHIMOTO
RTXKI4G 
May 22, 2001 
Ikuo Nishimoto, a professor of pharmacology and neurosciences at Keio University in Tokyo, talks to reporters... 
Tokyo, Japan 
Ikuo Nishimoto, a professor of pharmacology and neurosciences at Keio University in Tokyo, talks to ..... 
Ikuo Nishimoto, a professor of pharmacology and neurosciences at Keio University in Tokyo, talks to reporters at his office at the university May 22, 2001. Japanese scientists have discovered a substance which could become the world's first cure for Alzheimer's disease, head researcher Nishimoto said on Tuesday. Alzheimer's disease, which kills brain cells and shrinks the brain causing dementia in patients, is one of the most disturbing disorders among the aged. 
HEALTH JAPAN ALZHEIMER'S
RTRILWR 
May 22, 2001 
Ikuo Nishimoto, a professor of pharmacology and neurosciences at Keio University in Tokyo, smiles duirng... 
Tokyo, Japan 
KEIO UNIVERSITY PROFESSOR NISHIMOTO SMILES DURING INTERVIEW AT UNIVERSITY OFFICE IN TOKYO. 
Ikuo Nishimoto, a professor of pharmacology and neurosciences at Keio University in Tokyo, smiles duirng an interview at his office at the university May 22, 2001. Japanese scientists have discovered a substance which could become the world's first cure for Alzheimer's disease, head researcher Nishimoto said on Tuesday. Alzheimer's disease, which kills brain cells and shrinks the brain causing dementia in patients, is one of the most disturbing disorders among the aged.

TA/CC 
HEALTH JAPAN ALZHEIMER'S
RTRILWH 
May 22, 2001 
Ikuo Nishimoto, a professor of pharmacology and neurosciences at Keio University in Tokyo, talks to reporters... 
Tokyo, Japan 
KEIO UNIVERSITY PROFESSOR NISHIMOTO TALKS TO REPORTERS AT OFFICE IN TOKYO. 
Ikuo Nishimoto, a professor of pharmacology and neurosciences at Keio University in Tokyo, talks to reporters at his office at the university May 22, 2001. Japanese scientists have discovered a substance which could become the world's first cure for Alzheimer's disease, head researcher Nishimoto said on Tuesday. Alzheimer's disease, which kills brain cells and shrinks the brain causing dementia in patients, is one of the most disturbing disorders among the aged.

TA/CC 
GILMAN
RTXF8J4 
October 10, 1994 
Alfred Gilman, 53, chairman of the pharmacology department at the University of Texas Southwestern, will... 
Alfred Gilman, 53, chairman of the pharmacology department at the University of Texas Southwestern, ..... 
Alfred Gilman, 53, chairman of the pharmacology department at the University of Texas Southwestern, will share the Nobel Prize for Medicine, it was announced October 10, with Martin-Rodbell, 68. They won for the discovery of G-proteins and their role in showing how the human body's cells communicate with each other 
Sort by 
Display 
Items per page 
Page 
of 1